BioMarin Pharmaceutical Inc. (BMRN) NASDAQ
53.32
-1.71(-3.11%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
53.32
-1.71(-3.11%)
Currency In USD
| Market Cap | 11.4B |
| Enterprise Value | 10.73B |
| P/E Ratio | 38.19 |
| PEG Ratio | -0.78 |
| Price/Sales Ratio | 3.18 |
| Price/Book Ratio | 1.65 |
| Enterprise/Revenue | 2.94 |
| Enterprise/EBITDA | 19.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.14 |
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
| Revenue | 3.22B |
| Revenue/Share | 16.84 |
| Gross Profit | 2.48B |
| EBITDA | 572.94M |
| Net Income | 348.9M |
| Diluted EPS | 1.8 |
| Total Cash | 2.22B |
| Total Cash/Share | 11.55 |
| Total Debt | 1.44B |
| Total Debt/Equity | 0.23 |
| Current Ratio | 5.81 |
| Book Value Per Share | 32.27 |
| 52-Week Change | -6.54 |
| 52-Week High | 66.28 |
| 52-Week Low | 49.26 |
| Moving Average 50 Days | 54.22 |
| Moving Average 200 Days | 55.82 |
| Average Volume | 2.03M |
| Shares Outstanding | 193.28M |
| % Held by Institutions | 95.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |